Mankind Pharma Ltd. Financial Overview
Mankind Pharma Ltd.'s market cap is currently ₹869.53B. The company's EPS TTM is ₹12.4; its P/E ratio is 49.38; and it has a dividend yield of 0.05%. Mankind Pharma Ltd. is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is ₹13.15. See an overview of income statement, balance sheet, and cash flow financials.
